Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 355-361

  Schulz, Stefanie ^a   Sibbing, Dirk ^a   Braun, Sigmund ^a   Morath, Tanja ^a   Mehilli, Julinda ^a   Massberg, Steffen ^a   Byrne, Robert A ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; HEPARIN; HIRULOG;

AGED; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE; REVASCULARIZATION; RISK ASSESSMENT; STENT THROMBOSIS; THROMBOCYTE; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 77955465123     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.003     Document Type: Article

References (33)

1. Kastrati A., Mehilli J., and Pache J. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
2. Schomig A., Neumann F.J., and Kastrati A. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089
3. Sibbing D., Braun S., and Morath T. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
4. Willerson J.T., Yao S.K., and McNatt J. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury Proc Natl Acad Sci USA 88 1991 10624 10628
5. Unterberg C., Sandrock D., and Nebendahl K. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty J Am Coll Cardiol 26 1995 1747 1754
6. Evans D.J., Jackman L.E., and Chamberlain J. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis Circulation 119 2009 116 122
7. Cutlip D.E., Windecker S., and Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
8. The TIMI Study Group Definitions used in TIMI trials Available at http://www.timi.org Last accessed August 10th, 2009
9. Ip J.H., Fuster V., and Israel D. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty J Am Coll Cardiol 17 1991 77B 88B
10. Le Breton H., Plow E.F., and Topol E.J. Role of platelets in restenosis after percutaneous coronary revascularization J Am Coll Cardiol 28 1996 1643 1651
11. Ali S., Davis M.G., and Becker M.W. Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor J Biol Chem 268 1993 17397 17403
12. Ferns G.A., Raines E.W., and Sprugel K.H. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF Science 253 1991 1129 1132
13. Crowley S.T., Dempsey E.C., and Horwitz K.B. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate Circulation 90 1994 1908 1918
14. Weiss R.H., and Nuccitelli R. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells J Biol Chem 267 1992 5608 5613
15. Hermann A., Rauch B.H., and Braun M. Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel Platelets 12 2001 74 82
16. Evangelista V., Manarini S., and Dell'Elba G. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation Thromb Haemost 94 2005 568 577
17. Hermann A., Weber A.A., and Schror K. Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells Thromb Res 105 2002 173 175
18. Herbert J.M., Tissinier A., and Defreyn G. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits Arterioscler Thromb 13 1993 1171 1179
19. Taylor R.R., Gibbons F.A., and Cope G.D. Effects of low-dose aspirin on restenosis after coronary angioplasty Am J Cardiol 68 1991 874 878
20. Schwartz L., Bourassa M.G., and Lesperance J. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty N Engl J Med 318 1988 1714 1719
21. Kastrati A., Schuhlen H., and Hausleiter J. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial Circulation 96 1997 462 467
22. Urban P., Buller N., and Fox K. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty Br Heart J 60 1988 485 488
23. Ellis S.G., Roubin G.S., and Wilentz J. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty Am Heart J 117 1989 777 782
24. Serruys P.W., Herrman J.P., and Simon R. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators N Engl J Med 333 1995 757 763
25. Serruys P.W., Rutsch W., and Heyndrickx G.R. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT) Circulation 84 1991 1568 1580
26. Savage M.P., Goldberg S., and Bove A.A. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II) Circulation 92 1995 3194 3200
27. Muller I., Seyfarth M., and Rudiger S. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93 (Pubitemid 32973418)
28. von Beckerath N., Taubert D., and Pogatsa-Murray G. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial Circulation 112 2005 2946 2950
29. Marso S.P., Lincoff A.M., and Ellis S.G. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy Circulation 100 1999 2477 2484
30. Mehilli J., Kastrati A., and Schuhlen H. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Circulation 110 2004 3627 3635
31. Choi E.T., Engel L., and Callow A.D. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA J Vasc Surg 19 1994 125 134
32. Lundgren C.H., Sawa H., and Fujii S. Inhibition of neointimal hyperplasia after balloon injury by local delivery of cyclic arginine-glycine-aspartic acid peptide targeting vitronectin receptor [abstract] J Am Coll Cardiol 83A 1995 25
33. Friedman R.J., Stemerman M.B., and Wenz B. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization J Clin Invest 60 1977 1191 1201